IL6 and cancer: Wt p53 reduced the ability of IL-6 to enhance the synthesis and secretion of fibrinogen and α1-antichymytrypsinogen (ACT) (a pathway requiring C/EBP transcription factors) [58]; the cancer-derived mutants of p53 lost this ability.